CALCIUM DEPOSITS/TURNING TO STONE
|
Reprinted with permission from our Preferred Product Partner Life Extension
By William Faloon As we age, our soft tissues harden as a result of calcium infiltration. This calcification process is a major contributor to degenerative disease. Vitamin K functions to keep calcium out of soft tissues. New findings reveal that a vitamin K deficit creates more vascular calcification than initially thought. A recent study showed when women were given a drug that blocks vitamin K, there was a 50% greater prevalence of arterial calcification compared to women not taking this drug (warfarin). This pathological effect occurred in as little as one month.1 This study showed that longer term use of warfarin was associated with even greater arterial calcification prevalence. Kidney dialysis patients suffer severe arterial calcification with cardiovascular disease accounting for almost half of all their deaths.2 A clinical study examined vitamin K levels in dialysis patients. The results showed that93% of the patients were at risk for arterial calcification. This risk was shown to be reduced with vitamin K2supplementation.3 The quotation below comes from a report published by the American Heart Association.4 Despite this indisputable data, doctors today typically do nothing to protect their aging patients from the devastating impact of vascular calcification. This article briefly describes how proper use of vitamin K can markedly protect our soft tissues against calcification. “Most individuals aged over 60 years have progressively enlarging deposits of calcium mineral in their major arteries.5 This vascular calcification reduces aortic and arterial elastance, which impairs cardiovascular hemodynamics, resulting in substantial morbidity and mortality6-8 in the form of hypertension, aortic stenosis, cardiac hypertrophy, myocardial and lower-limb ischemia, congestive heart failure, and compromised structural integrity.9-11 The severity and extent of mineralization reflect atherosclerotic plaque burden12 and strongly and independently predict cardiovascular morbidity and mortality.”13 Source: American Heart Association A search of the National Library of Medicine data base using the term “vascular calcification” at the time of this writing turns up the following numbers of published scientific articles: Year New Articles 1982 16 1994 53 2004 214 2008 373 2014 700+ The total number of articles that discuss arterial calcification in the National Library of Medicine as of April, 2015, is over 6,400. The surge from a mere 16 articles in 1982 to over 6,400 today is a reflection of the exponential increase in knowledge about this widespread pathological process. The problem is that this lifesaving data is not being translated into clinical medical practice where it is urgently needed to protect aging humans against a host of cardio-vascular disorders. Calcification And HypertensionWhen arteries are soft and elastic, they readily expand and contract with each heartbeat. As arteries harden (calcify) and lose youthful elasticity, there is a progressive elevation in blood pressure.14 This happens because the heart is forced to beat stronger to force blood into the increasingly rigid arterial system. Calcification of the large artery exiting the heart (the aorta) helps explain why blood pressure elevates as people age. A hallmark sign of long-term hypertension is enlargement of the heart’s left ventricle,15 which is the chamber of the heart that pushes blood into the aorta from where it is then distributed throughout the body. The increase in cardiac workload caused by aortic rigidity (calcification) contributes to heart failure that afflicts over 5 million Americans.16,17 Aortic Valve Stenosis A dilemma faced by elderly persons is progressive dysfunction of the valve between their heart and aorta that opens and closes with each heartbeat. When the aortic valve fails to completely close, blood regurgitates back into the left ventricle of the heart.18,19Without surgical replacement/repair of the aortic valve, death from congestive heart failure often occurs.20 Elderly persons are challenged to fully recover from aortic valve replacement, though newer intra-arterial techniques are becoming available whereby an artificial valve is threaded through the aorta and sewn into place.21 Those with successful mechanical valve replacements usually require anticoagulant drug therapy for life, which poses its own complicated set of side effects.22 It used to be thought that aortic stenosis was caused by a lifetime of “wear and tear.”23 It is now clear that calcification of the aortic valve leaflets is a cause of aortic valve failure, along with chronic inflammation, elevated glucose, high homocysteine, and low magnesium.24-31 Coronary Artery Calcification Blockage of the coronary arteries that feed the heart muscle necessitates enormous amounts of hospital expenditures each year in the form of open heart coronary bypass surgeries and intra-arterial “stenting” procedures. Interestingly, when open heart surgery is performed to replace a calcified aortic valve, the surgeon will often also bypass blocked coronary arteries in the same patient.32 This is not surprising since coronary atherosclerosis and aortic valve stenosis have similar underlying causes such as elevated homocysteine, chronic inflammation, and calcification.33-36 Calcification plays a significant role in accelerating the formation of the atherosclerotic plaque that narrows the coronary arteries of aging humans. In patients with coronary artery disease, calcification is present in90% of cases.37,38 Clinically, vascular calcification is now accepted as a valuable predictor of coronary heart disease.39 Yet most cardiologists use it only as a diagnostic marker (the coronary calcium score test) as opposed to directly treating the underlying calcification pathology.40 What Causes Arteries To Calcify? Many of the known risk factors that underlie atherosclerosis have been shown to promote arterial calcification. These include elevated LDL cholesterol, elevated homocysteine, diabetes, kidney failure, chronic inflammation, and oxidative stress.33,41-55 Additional calcification contributors include low magnesium (a natural calcium channel blocker), hormone imbalance, and excess blood calcium (caused by hyperparathyroidism).56-66 An underappreciated, major reason our vascular system turns to stone (calcifies) as we age, however, is inadequate intake of vitamin K. As you’ll read next, a low blood level of vitamin K2 causes a protein in the vascular wall to bind calcium to arteries, heart valves, and other soft tissues. A Calcium Inhibitor In Need Of Vitamin KMatrix Gla-protein is a vitamin K-dependent protein, and it must be carboxylated to function properly. Poor vitamin K status leads to inactive uncarboxylated matrix Gla, which enables calcium to accumulate in soft tissues.67-69 Failure to optimally carboxylate matrix Gla-protein is a risk factor for atherosclerosis, coronary heart attack, and kidney disease.70-74 The title of a 2008 study that examined the impact of cardiovascular calcification is: “Matrix Gla-Protein: The Calcification Inhibitor In Need Of Vitamin K.”75,76 Matrix Gla-protein lines our vascular system and its function is governed by the quantity of vitamin K in our bloodstream. When vitamin K levels are less than optimal, matrix Gla-protein allows calcium to infiltrate into our soft tissues similar to the way calcium absorbs into bone. When you hear the term “hardening of the arteries,” this can literally mean one’s previously flexible blood vessels are turning into rigid (calcified) bony structures. With optimal levels of vitamin K, matrix Gla-protein becomes activated to shield calcium from entering arteries, heart valves, and other soft tissues. Said differently, vitamin K functions as a control switch. When matrix Gla-protein is turned “on” by vitamin K, itblocks calcium from entering soft tissues. In the absence of adequate vitamin K, the matrix Gla-proteinswitch is turned “off” and calcium quickly infiltrates into soft tissues. So the title of the 2008 study is quite revealing in that matrix Gla-protein is clearly a “ calcification inhibitor in need of vitamin K.” WHAT IS MATRIX GLA-PROTEIN? Early forms of life emanated from calcium-rich oceans, which required primitive organisms to develop mechanisms to prevent widespread calcium crystallization of living soft tissues.77 A prominent calcium-blocking mechanism is through activation of a protein called matrix gamma-carboxyglutamic acid, more commonly referred to asmatrix Gla-protein or matrix Gla.78 The key to how matrix Gla-protein functions lies with its “carboxyl” group.Matrix Gla must be carboxylated to function properly.74 In the presence of vitamin K2, matrix Gla-protein becomes “carboxylated,” which means it’s being turned “ on” to repel calcium infiltration.74 Insufficient vitamin K2 results in matrix Gla being inadequately carboxylated or turned “off,” which means it’s unable to inhibit calcium infiltration into soft tissues. To keep our natural calcium inhibitor matrix Gla continuously carboxylated, we need to provide it with a steady supply of vitamin K2. This is easy to do with one-per-day dosing of the proper forms of vitamin K. What Happens When Vitamin K Is Acutely Withdrawn? A recent study provided real-world evidence of what happens to aging humans who are deprived of vitamin K. Warfarin is an anticoagulant drug that functions by antagonizing the effects of vitamin K in the body.79 This drug has been sold under the trade name Coumadin® for many decades. Scientists were long ago aware that warfarin users suffered accelerated arterial calcification, but until recently, there was no alternative to protect high-risk patients from a thrombotic (arterial clotting) event, such as an ischemic stroke. A study published in 2015 evaluated 451 women using mammograms to measure arterialcalcification. After just one month or more of warfarin drug therapy, the prevalence of arterial calcification increased by an astounding50% compared to that in untreated women. When these women were evaluated again after five years, the prevalence of arterial calcification increased almost 3-fold.1 This new human trial provides stark evidence of rapid calcification occurring in response to vitamin K withdrawal caused by warfarin (a vitamin K antagonist drug.) We discuss the pros and cons of anticoagulant drugs that may be used in place of warfarin in this month’s issue of Life Extension® magazine. What Happens When Vitamin K Is Introduced To Deficient Patients?Kidney failure patients are kept alive by thrice weekly dialysis treatments. While the advent of hemodialysis has added countless human life years, it produces devastating side effects over the longer term. Over 50% of hemodialysis patients have vascular calcification, a major cause of cardiovascular disease. Cardiovascular disease accounts for about 50% of all deaths in these patients.80-82 A study was done to evaluate the effects of varying doses of the MK-7 form of vitamin K2 on markers of arterial calcification including carboxylation (activation) of matrix Gla-proteins.83 MK-7 (menaquinone-7) is a unique form of vitamin K2 because it remains active in the body for 24 hours and longer.84 At baseline, hemodialysis patients had a 4.5-fold higher level of uncarboxylated matrix Gla compared to controls.83 Daily doses of MK-7 of 45 mcg, 135 mcg, and 360 mcg were then administered over a six-week period. THREE FORMS OF VITAMIN K Based on the totality of evidence and low cost, it is prudent to take a supplement that contains multiple forms of vitamin K. The three forms of vitamin K most applicable to human health are:
Results were measured by the reduction of uncarboxylated matrix Gla and other measures of systemiccalcification. Recall that when matrix Gla is under-carboxylated, it enables calcification of its surrounding tissue. Supplementation with the MK-7 form of vitamin K2 reduced uncarboxylated matrix Gla by 36.7% in the 135 mcg dose group and 61.1% in the 360 mcg dose group. In the group given 360 mcg per day of MK-7, the favorable response rate was a remarkable 93%.83 When vitamin K2 supplementation was ceased in these dialysis patients, plasma levels of uncarboxylatedmatrix Gla-protein increased significantly, which indicated these high-risk individuals were once again vulnerable to severe vascular calcification. Can Calcification Be Reversed? Most adults probably suffer some degree of calcification, as intake of vitamin K in Western societies remains at epidemic low levels. Some of us are severely calcified because of medical disorders requiring dialysis or the drug warfarin, or we allowed blood levels of homocysteine, LDL, or glucose to remain too high for too long. So the question begs is there anything we can do now to reverse the accumulation of calcium in our arteries, heart valves, glands, and other soft tissues? We found one animal study published in 2007 suggesting that high-dose vitamin K might work. The authors of the study wrote: 99 “Given that arterial calcifications are predictive of cardiovascular events, regression of arterial calcification may help to reduce the risk of death in people with chronic kidney disease and coronary artery disease.” The study involved four groups of rats who were all initially fed a six-week diet that contained warfarin to induce calcium buildup in the blood vessels. This diet also included a low-dose (normal) vitamin K1 to ensure the animals were not vitamin K deficient. The rats were divided into several groups, of which the following four groups comprised the main part of the experiment: Group 1: Continue thewarfarin plus normal K1 diet; Group 2: Stop warfarin, but continue with normal dose of vitamin K1; Group 3: Stop warfarin, but use a high-dose of vitamin K1; Group 4: Stop warfarin, but add high-dose of MK-4 formof vitamin K2. During the initial six weeks of warfarin plus normal K1, all animals showed a significant increase in arterial calcification. In the groups receiving high-dose vitamin K1 or K2 (MK-4), not only was there no further arterial calcium accumulation, but there was a greater than 37% reduction of previously accumulated arterial calcification after six weeks. After 12 weeks, there was a 53% reduction in accumulated arterial calcium deposits. The groups receiving the high-dose vitamin K1 and K2 also showed a reversal in carotid artery stiffness.99 This study provides intriguing evidence that warfarin-induced calcification may be reversible by high vitamin K intake. An estimate of the human equivalent dose given to the rats whose arterial calcification was reversed is difficult to precisely calculate because of many variables involved. Our calculations based on estimates of food consumption and animal body weight suggest that the human equivalent dose of the vitamin K2 (MK-4)used in this study is in the range of approximately 52,000 mcg to 97,000 mcg per day (i.e. 52 mg to 97 mgper day). Since the RDA for vitamin K is only 90 to 120 mcg, the dose of vitamin K used in this rat study may seem extremely high. Yet in Japan, the MK-4 form of vitamin K2 is approved as a drug to treat osteoporosis in humans, and the daily dose is 45,000 mcg (45 mg), which has not been reported to have any toxic effects.120-123 Most Life Extension® members take a combination supplement that provides 1,000 mcg of vitamin K1, 1,000mcg of vitamin K2 (MK-4), and 200 mcg of vitamin K2 (MK-7). These are high doses compared to dietary supplement industry standards, and one could postulate that taking these daily doses over an extended time period might induce a regression of arterial calcification, but more human research is needed to establish this. Some members are taking higher doses of vitamin K now with the objective of reversing accumulated soft tissue calcification. Systemic Calcification Cardiovascular tissues are particularly prone to calcium infiltration. The calcification process, however, is also commonly observed in the skin, kidney, tendons, glands, and other soft tissues as a result of disease, and/or aging.124-132 How To Properly Supplement With Vitamin KA review of the published scientific literature provides a rationale for aging people to supplement with all three vitamin K forms, i.e. vitamin K1, vitamin K2 (MK-4), and vitamin K2 (MK-7). Since vitamin K is fat-soluble, taking it with the fattiest meal of the day will greatly augment absorption into one’s bloodstream. A lot of members ask why they cannot take just the MK-7 form of vitamin K2 since this has long-acting effects in the body and has demonstrated powerful calcium blocking properties. Our response is that vitamin K1 and MK-4 have demonstrated impressive results in other studies, so it is best to take a formula that contains all three forms of vitamin K. As mentioned already, the MK-4 form of vitamin K2 has been used in high doses as a prescription drug in Japan to treat osteoporosis. Since vitamin K1 and MK-4 are inexpensive, it makes sense to include them with the long-acting MK-7 form of vitamin K2 to inhibit and possibly reverse as much vascular calcification as possible, while providing support for strong bones. Why Doctors Are Apprehensive About Vitamin KIn 1999, one of our scientific advisors recommended to me that aging people supplement with vitamin K. Vitamin K is known as the “coagulation vitamin” because of the critical role in plays in essential blood clotting. I was initially apprehensive because abnormal clotting inside blood vessels (thrombosis) is a leading cause of death in the elderly. 133,134 Thrombosis is a frequent underlying cause of coronary occlusion heart attacks and ischemic strokes.135,136 One might think that taking higher amounts of vitamin K would increase thrombotic risk. This concern, however, has no basis in reality. The reason is that only small amounts of vitamin K are required to fully saturate coagulation proteins .137 Once coagulation proteins are fully saturated by vitamin K, then there is no increased thrombotic risk in response to additional vitamin K intake. The misconception about the role vitamin K plays in coagulation is contributing to the epidemic of diseases caused by vascular calcification. A plethora of published studies indicate that the most common degenerative diseases afflicting aging humans could be prevented by taking the proper doses of vitamin K. What mainstream doctors still don’t understand is vitamin K’s critical role of blocking the calcification of heart valves, arterial linings, and other soft tissues, while helping to keep calcium in bone where it is needed. Eye-opening recent studies shed light on the importance for people to optimize their intake of vitamin K to protect against soft tissue calcification. An urgent need exists to convey this information to the medical community. This may not happen any time soon because vitamin K is sold as a low-cost dietary supplement and not an expensive prescription drug. For longer life, William Faloon |
|